Sinovac Biotech annual gross margin
2009
2010
2011
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Gross Margin Growth & History (SVA)
Sinovac Biotech's gross margin was 67.87% for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 67.87% | +6.80 pp |
| 2024 | 2024-12-31 | 61.07% | −7.70 pp |
| 2023 | 2023-12-31 | 68.77% | +13.44 pp |
| 2022 | 2022-12-31 | 55.33% | −39.56 pp |
| 2021 | 2021-12-31 | 94.89% | +8.05 pp |
| 2020 | 2020-12-31 | 86.84% | +0.04 pp |
| 2019 | 2019-12-31 | 86.80% | −2.43 pp |
| 2018 | 2018-12-31 | 89.23% | +0.84 pp |
| 2017 | 2017-12-31 | 88.39% | +19.31 pp |
| 2016 | 2016-12-31 | 69.08% | +6.25 pp |
| 2011 | 2011-12-31 | 62.83% | +12.88 pp |
| 2010 | 2010-12-31 | 49.95% | −26.22 pp |
| 2009 | 2009-12-31 | 76.17% | — |
Sinovac Biotech quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Sinovac Biotech gross margin trends
Over the last five reported fiscal years, Sinovac Biotech's gross margin decreased from 86.84% to 67.87%, a change of −18.98 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech filings at SEC.gov ↗